Alector Investors
Alector is an innovative angel investment group based in San Francisco, California, founded in 2013 The organization focuses on advancing biotechnology and therapeutic solutions to address neurodegenerative diseases With a significant investment scale of $176,000,000, Alector is dedicated to supporting early-stage companies that demonstrate potential for impactful breakthroughs in healthcare The group combines expertise in science and business to foster the development of transformative therapies Alectors commitment to innovation positions it as a key player in the biotechnology investment landscape
Investors
Headquarters:
USA
Last Funding Date:
2018-07-25
Total Funding:
194500000
Last Funding Type:
Series E
Number Of Exists:
101-250
Founded Date:
2013
Investors Number:
20
Industry:
FemTech
Employee Number:
101-250
Estimated Revenue:
$10M to $50M
Investor Type:
Angel Groups
Funding Status:
IPO